Details for New Drug Application (NDA): 202068
The generic ingredient in METHIMAZOLE is methimazole. There is one drug master file entry for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the methimazole profile page.
Summary for 202068
| Tradename: | METHIMAZOLE |
| Applicant: | Rising |
| Ingredient: | methimazole |
| Patents: | 0 |
Pharmacology for NDA: 202068
| Mechanism of Action | Thyroid Hormone Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 202068
Suppliers and Packaging for NDA: 202068
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| METHIMAZOLE | methimazole | TABLET;ORAL | 202068 | ANDA | Rising Pharma Holdings, Inc. | 64980-264 | 64980-264-01 | 100 TABLET in 1 BOTTLE (64980-264-01) |
| METHIMAZOLE | methimazole | TABLET;ORAL | 202068 | ANDA | Rising Pharma Holdings, Inc. | 64980-265 | 64980-265-01 | 100 TABLET in 1 BOTTLE (64980-265-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Mar 7, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Mar 7, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
